109 related articles for article (PubMed ID: 28887433)
21. NBEAL2 is required for neutrophil and NK cell function and pathogen defense.
Sowerby JM; Thomas DC; Clare S; Espéli M; Guerrero JA; Hoenderdos K; Harcourt K; Marsden M; Abdul-Karim J; Clement M; Antrobus R; Umrania Y; Barton PR; Flint SM; Juss JK; Condliffe AM; Lyons PA; Humphreys IR; Chilvers ER; Ouwehand WH; Dougan G; Smith KG
J Clin Invest; 2017 Sep; 127(9):3521-3526. PubMed ID: 28783043
[TBL] [Abstract][Full Text] [Related]
22. Platelet α-granules modulate the inflammatory response under systemic lipopolysaccharide injection in mice.
Tariket S; Guerrero JA; Garraud O; Ghevaert C; Cognasse F
Transfusion; 2019 Jan; 59(1):32-38. PubMed ID: 30394544
[TBL] [Abstract][Full Text] [Related]
23. Nbeal2 Deficiency Increases Organ Damage but Does Not Affect Host Defense During Gram-Negative Pneumonia-Derived Sepsis.
Claushuis TAM; de Stoppelaar SF; de Vos AF; Grootemaat AE; van der Wel NN; Roelofs JJTH; Ware J; Van't Veer C; van der Poll T
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1772-1784. PubMed ID: 29930006
[TBL] [Abstract][Full Text] [Related]
24. The Nbeal2(-/-) mouse as a model for the gray platelet syndrome.
Deppermann C; Nurden P; Nurden AT; Nieswandt B; Stegner D
Rare Dis; 2013; 1():e26561. PubMed ID: 25003009
[TBL] [Abstract][Full Text] [Related]
25. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome.
Albers CA; Cvejic A; Favier R; Bouwmans EE; Alessi MC; Bertone P; Jordan G; Kettleborough RN; Kiddle G; Kostadima M; Read RJ; Sipos B; Sivapalaratnam S; Smethurst PA; Stephens J; Voss K; Nurden A; Rendon A; Nurden P; Ouwehand WH
Nat Genet; 2011 Jul; 43(8):735-7. PubMed ID: 21765411
[TBL] [Abstract][Full Text] [Related]
26. Gray platelet syndrome: NBEAL2 mutations are associated with pathology beyond megakaryocyte and platelet function defects.
Pluthero FG; Kahr WHA
J Thromb Haemost; 2021 Feb; 19(2):318-322. PubMed ID: 33300270
[No Abstract] [Full Text] [Related]
27. NBEAL2 deficiency in humans leads to low CTLA-4 expression in activated conventional T cells.
Delage L; Carbone F; Riller Q; Zachayus JL; Kerbellec E; Buzy A; Stolzenberg MC; Luka M; de Cevins C; Kalouche G; Favier R; Michel A; Meynier S; Corneau A; Evrard C; Neveux N; Roudières S; Pérot BP; Fusaro M; Lenoir C; Pellé O; Parisot M; Bras M; Héritier S; Leverger G; Korganow AS; Picard C; Latour S; Collet B; Fischer A; Neven B; Magérus A; Ménager M; Pasquier B; Rieux-Laucat F
Nat Commun; 2023 Jun; 14(1):3728. PubMed ID: 37349339
[TBL] [Abstract][Full Text] [Related]
28. The Transcription Factor Ehf Is Involved in TGF-β-Induced Suppression of FcεRI and c-Kit Expression and FcεRI-Mediated Activation in Mast Cells.
Yamazaki S; Nakano N; Honjo A; Hara M; Maeda K; Nishiyama C; Kitaura J; Ohtsuka Y; Okumura K; Ogawa H; Shimizu T
J Immunol; 2015 Oct; 195(7):3427-35. PubMed ID: 26297757
[TBL] [Abstract][Full Text] [Related]
29. Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome.
Sims MC; Mayer L; Collins JH; Bariana TK; Megy K; Lavenu-Bombled C; Seyres D; Kollipara L; Burden FS; Greene D; Lee D; Rodriguez-Romera A; Alessi MC; Astle WJ; Bahou WF; Bury L; Chalmers E; Da Silva R; De Candia E; Deevi SVV; Farrow S; Gomez K; Grassi L; Greinacher A; Gresele P; Hart D; Hurtaud MF; Kelly AM; Kerr R; Le Quellec S; Leblanc T; Leinøe EB; Mapeta R; McKinney H; Michelson AD; Morais S; Nugent D; Papadia S; Park SJ; Pasi J; Podda GM; Poon MC; Reed R; Sekhar M; Shalev H; Sivapalaratnam S; Steinberg-Shemer O; Stephens JC; Tait RC; Turro E; Wu JKM; Zieger B; ; Kuijpers TW; Whetton AD; Sickmann A; Freson K; Downes K; Erber WN; Frontini M; Nurden P; Ouwehand WH; Favier R; Guerrero JA
Blood; 2020 Oct; 136(17):1956-1967. PubMed ID: 32693407
[TBL] [Abstract][Full Text] [Related]
30. VPS33B regulates protein sorting into and maturation of α-granule progenitor organelles in mouse megakaryocytes.
Bem D; Smith H; Banushi B; Burden JJ; White IJ; Hanley J; Jeremiah N; Rieux-Laucat F; Bettels R; Ariceta G; Mumford AD; Thomas SG; Watson SP; Gissen P
Blood; 2015 Jul; 126(2):133-43. PubMed ID: 25947942
[TBL] [Abstract][Full Text] [Related]
31. Defective Zn
Kiran Gotru S; van Geffen JP; Nagy M; Mammadova-Bach E; Eilenberger J; Volz J; Manukjan G; Schulze H; Wagner L; Eber S; Schambeck C; Deppermann C; Brouns S; Nurden P; Greinacher A; Sachs U; Nieswandt B; Hermanns HM; Heemskerk JWM; Braun A
Sci Rep; 2019 Jun; 9(1):8333. PubMed ID: 31171812
[TBL] [Abstract][Full Text] [Related]
32. Immune dysregulation, autoimmunity, and granule defects in gray platelet syndrome.
Collins JH; Mayer L; Guerrero Lopez JA
J Thromb Haemost; 2023 Jun; 21(6):1409-1419. PubMed ID: 37028650
[TBL] [Abstract][Full Text] [Related]
33. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
Samayawardhena LA; Hu J; Stein PL; Craig AW
Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778
[TBL] [Abstract][Full Text] [Related]
34. GATA2 and Sp1 positively regulate the c-kit promoter in mast cells.
Maeda K; Nishiyama C; Ogawa H; Okumura K
J Immunol; 2010 Oct; 185(7):4252-60. PubMed ID: 20833840
[TBL] [Abstract][Full Text] [Related]
35. Thrombocytopenia and CD34 expression is decoupled from α-granule deficiency with mutation of the first growth factor-independent 1B zinc finger.
Rabbolini DJ; Morel-Kopp MC; Chen Q; Gabrielli S; Dunlop LC; Chew LP; Blair N; Brighton TA; Singh N; Ng AP; Ward CM; Stevenson WS
J Thromb Haemost; 2017 Nov; 15(11):2245-2258. PubMed ID: 28880435
[TBL] [Abstract][Full Text] [Related]
36. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice.
Deppermann C; Cherpokova D; Nurden P; Schulz JN; Thielmann I; Kraft P; Vögtle T; Kleinschnitz C; Dütting S; Krohne G; Eming SA; Nurden AT; Eckes B; Stoll G; Stegner D; Nieswandt B
J Clin Invest; 2013 Jul; 123(8):3331-42. PubMed ID: 23863626
[TBL] [Abstract][Full Text] [Related]
37. Defective cytoplasmic granule formation. I. Abnormalities affecting tissue mast cells and pancreatic acinar cells of beige mice.
Hammel I; Dvorak AM; Galli SJ
Lab Invest; 1987 Mar; 56(3):321-8. PubMed ID: 3821071
[TBL] [Abstract][Full Text] [Related]
38. A dominant-negative GFI1B mutation in the gray platelet syndrome.
Monteferrario D; Bolar NA; Marneth AE; Hebeda KM; Bergevoet SM; Veenstra H; Laros-van Gorkom BA; MacKenzie MA; Khandanpour C; Botezatu L; Fransen E; Van Camp G; Duijnhouwer AL; Salemink S; Willemsen B; Huls G; Preijers F; Van Heerde W; Jansen JH; Kempers MJ; Loeys BL; Van Laer L; Van der Reijden BA
N Engl J Med; 2014 Jan; 370(3):245-53. PubMed ID: 24325358
[TBL] [Abstract][Full Text] [Related]
39. Pleiotropic platelet defects in mice with disrupted FOG1-NuRD interaction.
Wang Y; Meng R; Hayes V; Fuentes R; Yu X; Abrams CS; Heijnen HF; Blobel GA; Marks MS; Poncz M
Blood; 2011 Dec; 118(23):6183-91. PubMed ID: 21989988
[TBL] [Abstract][Full Text] [Related]
40. A Case of Chronic Thrombocytopenia in a 17-Year-Old Female.
Riley R; Khan A; Pai S; Warmke L; Winkler M; Gunning W
Lab Med; 2019 Oct; 50(4):406-420. PubMed ID: 31228350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
